Not much news regarding the trials or status with FDA approvals, or partnerships.
Quarterly cash burn of nearly $32m, with only $77.5m on hand is a bit concerning. But as long as partnerships happen that should be ok.
I'm over simplifying and likely missing something, happy to be corrected!
- Forums
- ASX - By Stock
- Ann: Appendix 4C Quarterly Activity Report
MSB
mesoblast limited
Add to My Watchlist
36.9%
!
$2.45

Not much news regarding the trials or status with FDA approvals,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.45 |
Change
0.660(36.9%) |
Mkt cap ! $3.103B |
Open | High | Low | Value | Volume |
$1.90 | $2.48 | $1.90 | $49.83M | 21.97M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 70150 | $2.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.45 | 83195 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 50409 | 2.440 |
22 | 113984 | 2.430 |
16 | 441155 | 2.420 |
24 | 465588 | 2.410 |
97 | 447170 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.450 | 114711 | 24 |
2.460 | 72598 | 18 |
2.470 | 153760 | 15 |
2.480 | 138222 | 25 |
2.490 | 423313 | 23 |
Last trade - 15.26pm 18/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |